PAVmed Acquires CapNostics LLC

October 7, 2021

PAVmed Inc. (NASDAQ: PAVM) announced that a wholly owned subsidiary entered into a definitive membership interests purchase agreement to acquire North Carolina-based CapNostics, LLC, which manufactures EsophaCap, an FDA 510(k)-cleared and CE-mark certified esophageal cell collection device. The deal also includes long-term consulting and manufacturing agreements with CapNostics’ owner Martin Von Dyck and its contract manufacturer.

Buyers
PAVmed Inc.
Targets
CapNostics LLC
Sellers
Martin Von Dyck
Location
North Carolina, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.